Molecular Formula | C32H32BN2O2 |
Molar Mass | 487.43 |
Density | 1.19 |
garefloxacin | Garenoxacin development of a new fluoroquinolone antibacterial drugs, can be oral or injection, for the treatment of surgical and respiratory diseases. on 2019/7/16, National Medical Products Administration (NMPA) (NMPA) approval was obtained for the listing application (JXHS1300058) of garefloxacin mesylate submitted by Fushan Chemical Industry Corporation in China. garefloxacin Mesilate (Geninax), a fourth generation quinolone antibiotic, is effective in the treatment of both Gram-positive and gram-negative bacterial infections and was first discovered by Fushan Chemical Industries Corporation. The galefloxacin mesylate tablet can act as a bactericidal agent by inhibiting bacteria of DNA gyrase and topoisomerase IV; On the other hand, it can selectively inhibit bacterial topoisomerase (Top II). |